CA2959512A1 - Pixel array medical devices and methods - Google Patents
Pixel array medical devices and methods Download PDFInfo
- Publication number
- CA2959512A1 CA2959512A1 CA2959512A CA2959512A CA2959512A1 CA 2959512 A1 CA2959512 A1 CA 2959512A1 CA 2959512 A CA2959512 A CA 2959512A CA 2959512 A CA2959512 A CA 2959512A CA 2959512 A1 CA2959512 A1 CA 2959512A1
- Authority
- CA
- Canada
- Prior art keywords
- scalpet
- skin
- site
- incised
- skin pixels
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 365
- 230000007547 defect Effects 0.000 claims abstract description 168
- 210000003491 skin Anatomy 0.000 claims description 907
- 239000000758 substrate Substances 0.000 claims description 202
- 230000001464 adherent effect Effects 0.000 claims description 196
- 230000004044 response Effects 0.000 claims description 92
- 239000012528 membrane Substances 0.000 claims description 87
- 238000003306 harvesting Methods 0.000 claims description 70
- 230000007246 mechanism Effects 0.000 claims description 58
- 238000012546 transfer Methods 0.000 claims description 52
- 238000005520 cutting process Methods 0.000 claims description 50
- 230000004913 activation Effects 0.000 claims description 39
- 210000001519 tissue Anatomy 0.000 claims description 28
- 230000029663 wound healing Effects 0.000 claims description 28
- 230000008878 coupling Effects 0.000 claims description 22
- 238000010168 coupling process Methods 0.000 claims description 22
- 238000005859 coupling reaction Methods 0.000 claims description 22
- 210000003780 hair follicle Anatomy 0.000 claims description 22
- 206010029113 Neovascularisation Diseases 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 9
- 239000002184 metal Substances 0.000 claims description 9
- 229920000642 polymer Polymers 0.000 claims description 9
- 238000004140 cleaning Methods 0.000 claims description 2
- 230000000249 desinfective effect Effects 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 210000004209 hair Anatomy 0.000 description 71
- 238000002271 resection Methods 0.000 description 64
- 230000037390 scarring Effects 0.000 description 30
- 210000004761 scalp Anatomy 0.000 description 27
- 239000000853 adhesive Substances 0.000 description 24
- 230000001070 adhesive effect Effects 0.000 description 24
- 239000010410 layer Substances 0.000 description 21
- 210000004207 dermis Anatomy 0.000 description 20
- 230000035876 healing Effects 0.000 description 19
- 238000012377 drug delivery Methods 0.000 description 18
- 231100000241 scar Toxicity 0.000 description 18
- 230000002500 effect on skin Effects 0.000 description 17
- 230000008569 process Effects 0.000 description 17
- 210000002615 epidermis Anatomy 0.000 description 16
- 238000002054 transplantation Methods 0.000 description 16
- 238000002347 injection Methods 0.000 description 15
- 239000007924 injection Substances 0.000 description 15
- 230000036961 partial effect Effects 0.000 description 15
- 201000004384 Alopecia Diseases 0.000 description 14
- 201000010251 cutis laxa Diseases 0.000 description 13
- 208000027418 Wounds and injury Diseases 0.000 description 12
- 230000003111 delayed effect Effects 0.000 description 12
- 230000008021 deposition Effects 0.000 description 12
- 229940079593 drug Drugs 0.000 description 12
- 239000003814 drug Substances 0.000 description 12
- 238000001356 surgical procedure Methods 0.000 description 12
- 230000006378 damage Effects 0.000 description 11
- 239000011159 matrix material Substances 0.000 description 11
- 102000008186 Collagen Human genes 0.000 description 10
- 108010035532 Collagen Proteins 0.000 description 10
- 230000008602 contraction Effects 0.000 description 10
- 230000035800 maturation Effects 0.000 description 10
- 206010052428 Wound Diseases 0.000 description 9
- 230000008901 benefit Effects 0.000 description 9
- 229920001436 collagen Polymers 0.000 description 9
- 238000002316 cosmetic surgery Methods 0.000 description 9
- 238000005096 rolling process Methods 0.000 description 9
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 8
- 208000014674 injury Diseases 0.000 description 8
- 239000003589 local anesthetic agent Substances 0.000 description 8
- 230000002980 postoperative effect Effects 0.000 description 8
- 231100000360 alopecia Toxicity 0.000 description 7
- 206010068168 androgenetic alopecia Diseases 0.000 description 7
- 238000013459 approach Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 210000005195 occipital scalp Anatomy 0.000 description 7
- 210000004003 subcutaneous fat Anatomy 0.000 description 7
- 208000002847 Surgical Wound Diseases 0.000 description 6
- 210000000481 breast Anatomy 0.000 description 6
- 230000001413 cellular effect Effects 0.000 description 6
- 239000002131 composite material Substances 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 210000003127 knee Anatomy 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 5
- 210000000617 arm Anatomy 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 230000008733 trauma Effects 0.000 description 5
- 210000000689 upper leg Anatomy 0.000 description 5
- 206010006802 Burns second degree Diseases 0.000 description 4
- 208000032544 Cicatrix Diseases 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 4
- 206010039580 Scar Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000003698 anagen phase Effects 0.000 description 4
- 210000001099 axilla Anatomy 0.000 description 4
- 210000001217 buttock Anatomy 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 229960001340 histamine Drugs 0.000 description 4
- 238000007726 management method Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000037387 scars Effects 0.000 description 4
- 230000006641 stabilisation Effects 0.000 description 4
- 238000011105 stabilization Methods 0.000 description 4
- 230000003068 static effect Effects 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- 206010006803 Burns third degree Diseases 0.000 description 3
- 206010015995 Eyelid ptosis Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 210000000416 exudates and transudate Anatomy 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000003779 hair growth Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 230000036210 malignancy Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 201000003004 ptosis Diseases 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 206010006797 Burns first degree Diseases 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- 206010051814 Eschar Diseases 0.000 description 2
- 206010063560 Excessive granulation tissue Diseases 0.000 description 2
- 206010064503 Excessive skin Diseases 0.000 description 2
- 102000018997 Growth Hormone Human genes 0.000 description 2
- 108010051696 Growth Hormone Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- 206010041235 Snoring Diseases 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 238000002679 ablation Methods 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000007012 clinical effect Effects 0.000 description 2
- 238000005056 compaction Methods 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- 238000001804 debridement Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000001339 epidermal cell Anatomy 0.000 description 2
- 231100000333 eschar Toxicity 0.000 description 2
- 210000001723 extracellular space Anatomy 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 210000001126 granulation tissue Anatomy 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 239000000122 growth hormone Substances 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 210000003630 histaminocyte Anatomy 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000000394 mitotic effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000000651 myofibroblast Anatomy 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000003716 rejuvenation Effects 0.000 description 2
- 238000007634 remodeling Methods 0.000 description 2
- 230000036548 skin texture Effects 0.000 description 2
- 201000002859 sleep apnea Diseases 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 210000000106 sweat gland Anatomy 0.000 description 2
- 230000003797 telogen phase Effects 0.000 description 2
- 230000028016 temperature homeostasis Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 1
- 208000021657 Birth injury Diseases 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 108030001720 Bontoxilysin Proteins 0.000 description 1
- 108010068426 Contractile Proteins Proteins 0.000 description 1
- 102000002585 Contractile Proteins Human genes 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 208000004550 Postoperative Pain Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 108010057266 Type A Botulinum Toxins Proteins 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 210000001766 X chromosome Anatomy 0.000 description 1
- 108700029631 X-Linked Genes Proteins 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 230000036621 balding Effects 0.000 description 1
- 230000037365 barrier function of the epidermis Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229940089093 botox Drugs 0.000 description 1
- 229940053031 botulinum toxin Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 201000000475 female stress incontinence Diseases 0.000 description 1
- 229960004039 finasteride Drugs 0.000 description 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 230000003648 hair appearance Effects 0.000 description 1
- 238000002683 hand surgery Methods 0.000 description 1
- 208000002557 hidradenitis Diseases 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 210000001584 soft palate Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000010408 sweeping Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 231100000057 systemic toxicity Toxicity 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 229940126702 topical medication Drugs 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/322—Skin grafting apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/20—Surgical instruments, devices or methods, e.g. tourniquets for vaccinating or cleaning the skin previous to the vaccination
- A61B17/205—Vaccinating by means of needles or other puncturing devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/32053—Punch like cutting instruments, e.g. using a cylindrical or oval knife
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00747—Dermatology
- A61B2017/00752—Hair removal or transplantation
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plastic & Reconstructive Surgery (AREA)
- Transplantation (AREA)
- Surgical Instruments (AREA)
- Radiation-Therapy Devices (AREA)
- Prostheses (AREA)
- Massaging Devices (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462044060P | 2014-08-29 | 2014-08-29 | |
US201462044089P | 2014-08-29 | 2014-08-29 | |
US201462044078P | 2014-08-29 | 2014-08-29 | |
US201462044102P | 2014-08-29 | 2014-08-29 | |
US62/044,089 | 2014-08-29 | ||
US62/044,102 | 2014-08-29 | ||
US62/044,078 | 2014-08-29 | ||
US62/044,060 | 2014-08-29 | ||
US14/505,090 US10076354B2 (en) | 2010-12-17 | 2014-10-02 | Pixel array medical devices and methods |
US14/505,090 | 2014-10-02 | ||
PCT/US2015/047695 WO2016033584A1 (en) | 2014-08-29 | 2015-08-31 | Pixel array medical devices and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2959512A1 true CA2959512A1 (en) | 2016-03-03 |
Family
ID=55400735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2959512A Pending CA2959512A1 (en) | 2014-08-29 | 2015-08-31 | Pixel array medical devices and methods |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP3185788A4 (ja) |
JP (1) | JP2017528216A (ja) |
KR (1) | KR20170101184A (ja) |
CN (1) | CN107405164B (ja) |
AU (2) | AU2015308582A1 (ja) |
BR (1) | BR112017004112A2 (ja) |
CA (1) | CA2959512A1 (ja) |
MX (1) | MX2017002661A (ja) |
PH (1) | PH12017500349A1 (ja) |
SG (1) | SG11201701521RA (ja) |
WO (2) | WO2016033584A1 (ja) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10232129B2 (en) | 2008-12-02 | 2019-03-19 | Allergan, Inc. | Injection device |
US10772658B2 (en) * | 2010-12-17 | 2020-09-15 | Srgi Holdings, Llc | Pixel array medical systems, devices and methods |
WO2014130359A1 (en) | 2013-02-20 | 2014-08-28 | Cytrellis Biosystems, Inc. | Methods and devices for skin tightening |
US20140350518A1 (en) | 2013-05-23 | 2014-11-27 | Allergan, Inc. | Syringe extrusion accessory |
US20140350516A1 (en) | 2013-05-23 | 2014-11-27 | Allergan, Inc. | Mechanical syringe accessory |
KR20220010055A (ko) | 2013-08-09 | 2022-01-25 | 사이트렐리스 바이오시스템즈, 인크. | 비-열적 조직 절제를 사용한 피부 치료를 위한 방법 및 기구 |
US10953143B2 (en) | 2013-12-19 | 2021-03-23 | Cytrellis Biosystems, Inc. | Methods and devices for manipulating subdermal fat |
US10029048B2 (en) | 2014-05-13 | 2018-07-24 | Allergan, Inc. | High force injection devices |
US10226585B2 (en) | 2014-10-01 | 2019-03-12 | Allergan, Inc. | Devices for injection and dosing |
BR112017009805A2 (pt) | 2014-11-14 | 2017-12-26 | Cytrellis Biosystems Inc | dispositivos e métodos para ablação da pele |
US10433928B2 (en) | 2015-03-10 | 2019-10-08 | Allergan Pharmaceuticals Holdings (Ireland) Unlimited Company | Multiple needle injector |
CA3018976A1 (en) | 2016-03-29 | 2017-10-05 | Cytrellis Biosystems, Inc. | Devices and methods for cosmetic skin resurfacing |
RU2709154C1 (ru) | 2016-04-08 | 2019-12-16 | Аллерган, Инк. | Аспирационно-инъекционное устройство |
BR112018072717A2 (pt) * | 2016-05-03 | 2019-02-19 | Srgi Holdings, Llc | sistemas médicos de matriz pixel, dispositivos e métodos |
CN106166090B (zh) * | 2016-07-30 | 2018-10-02 | 汕头大学医学院 | 毛囊移植中转储存器 |
EP3515323A4 (en) | 2016-09-21 | 2020-06-10 | Cytrellis Biosystems, Inc. | COSMETIC RESTRUCTURING DEVICES AND METHODS |
DE102017106310B4 (de) * | 2017-03-23 | 2018-10-11 | Lavenir Bioscience Ag | Vorrichtung und Verfahren zur Erzeugung einer Mikrograftmatrix aus Vollhaut |
USD867582S1 (en) | 2017-03-24 | 2019-11-19 | Allergan, Inc. | Syringe device |
DE102020129157A1 (de) | 2020-11-05 | 2022-05-05 | Lavenir Bioscience Ag | Vorrichtung zur Entfernung wenigstens eines Objekts oder einer Agglomeration von Objek-ten aus der Haut |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6669685B1 (en) * | 1997-11-06 | 2003-12-30 | Biolase Technology, Inc. | Tissue remover and method |
US5922000A (en) * | 1997-11-19 | 1999-07-13 | Redfield Corp. | Linear punch |
US6589202B1 (en) * | 2000-06-29 | 2003-07-08 | Becton Dickinson And Company | Method and apparatus for transdermally sampling or administering a substance to a patient |
US6440096B1 (en) * | 2000-07-14 | 2002-08-27 | Becton, Dickinson And Co. | Microdevice and method of manufacturing a microdevice |
KR101134434B1 (ko) * | 2003-05-01 | 2012-04-09 | 메드제닉스 인코포레이티드 | 진피 미세 기관, 그를 생산 및 이용하기 위한 방법 및 장치 |
US8535299B2 (en) * | 2004-01-23 | 2013-09-17 | Joseph Giovannoli | Method and apparatus for skin reduction |
EP2157923A1 (en) * | 2007-06-26 | 2010-03-03 | Restoration Robotics, Inc. | Follicular unit harvesting tools including devices and their use for severing connective tissue |
US20100121307A1 (en) * | 2007-08-24 | 2010-05-13 | Microfabrica Inc. | Microneedles, Microneedle Arrays, Methods for Making, and Transdermal and/or Intradermal Applications |
KR101909645B1 (ko) * | 2010-05-07 | 2018-10-18 | 더 제너럴 하스피탈 코포레이션 | 조직이식과 조직복제 방법 및 장치 |
US9610093B2 (en) * | 2010-08-06 | 2017-04-04 | Kci Licensing, Inc. | Microblister skin grafting |
EP2667802B1 (en) * | 2011-01-28 | 2023-12-20 | The General Hospital Corporation | Method and apparatus for skin resurfacing |
US9468459B2 (en) * | 2011-04-20 | 2016-10-18 | Kci Licensing, Inc. | Skin graft devices and methods |
US20120323325A1 (en) * | 2011-06-16 | 2012-12-20 | Fulton Judith A | Autologous in situ tissue engineering |
US20120323139A1 (en) * | 2011-06-17 | 2012-12-20 | Will Richardson | Kit and method for extracting and storing a skin tissue sample |
AU2013302673B2 (en) * | 2012-08-14 | 2017-12-21 | The General Hospital Corporation | Method and apparatus for tissue harvesting |
JP6367220B2 (ja) * | 2012-12-06 | 2018-08-01 | エスアールジーアイ ホールディングス エルエルシーSrgi Holdings Llc | ピクセルアレイ医療デバイス及び方法 |
-
2015
- 2015-08-31 BR BR112017004112A patent/BR112017004112A2/pt not_active IP Right Cessation
- 2015-08-31 CA CA2959512A patent/CA2959512A1/en active Pending
- 2015-08-31 SG SG11201701521RA patent/SG11201701521RA/en unknown
- 2015-08-31 CN CN201580055986.5A patent/CN107405164B/zh active Active
- 2015-08-31 WO PCT/US2015/047695 patent/WO2016033584A1/en active Application Filing
- 2015-08-31 AU AU2015308582A patent/AU2015308582A1/en not_active Abandoned
- 2015-08-31 WO PCT/US2015/047721 patent/WO2016033586A1/en active Application Filing
- 2015-08-31 EP EP15836045.3A patent/EP3185788A4/en not_active Withdrawn
- 2015-08-31 KR KR1020177008576A patent/KR20170101184A/ko not_active Application Discontinuation
- 2015-08-31 MX MX2017002661A patent/MX2017002661A/es unknown
- 2015-08-31 JP JP2017511818A patent/JP2017528216A/ja active Pending
-
2017
- 2017-02-27 PH PH12017500349A patent/PH12017500349A1/en unknown
-
2020
- 2020-04-01 AU AU2020202310A patent/AU2020202310B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
WO2016033586A1 (en) | 2016-03-03 |
AU2020202310B2 (en) | 2021-01-28 |
CN107405164B (zh) | 2021-02-09 |
BR112017004112A2 (pt) | 2017-12-05 |
JP2017528216A (ja) | 2017-09-28 |
EP3185788A1 (en) | 2017-07-05 |
EP3185788A4 (en) | 2018-02-07 |
KR20170101184A (ko) | 2017-09-05 |
SG11201701521RA (en) | 2017-03-30 |
AU2015308582A1 (en) | 2017-04-20 |
MX2017002661A (es) | 2018-01-25 |
PH12017500349A1 (en) | 2017-07-17 |
AU2020202310A1 (en) | 2020-04-23 |
WO2016033584A1 (en) | 2016-03-03 |
CN107405164A (zh) | 2017-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2020202310B2 (en) | Pixel array medical devices and methods | |
US11844546B2 (en) | Pixel array medical systems, devices and methods | |
US10368904B2 (en) | Pixel array medical systems, devices and methods | |
US10772658B2 (en) | Pixel array medical systems, devices and methods | |
US20200281617A1 (en) | Pixel array medical devices and methods | |
AU2017218014B2 (en) | Pixel array medical systems, devices and methods | |
CA3053243C (en) | Pixel array medical systems, devices and methods | |
US20180344345A1 (en) | Pixel array medical systems, devices and methods | |
US20180344340A1 (en) | Pixel array medical systems, devices and methods | |
US11490952B2 (en) | Pixel array medical devices and methods | |
US20240216009A1 (en) | Pixel array medical systems, devices and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20200805 |
|
EEER | Examination request |
Effective date: 20200805 |
|
EEER | Examination request |
Effective date: 20200805 |
|
EEER | Examination request |
Effective date: 20200805 |
|
EEER | Examination request |
Effective date: 20200805 |
|
EEER | Examination request |
Effective date: 20200805 |
|
EEER | Examination request |
Effective date: 20200805 |
|
EEER | Examination request |
Effective date: 20200805 |
|
EEER | Examination request |
Effective date: 20200805 |
|
EEER | Examination request |
Effective date: 20200805 |